口头报告（Oral）

Oral摘要号486：新一代JAK2/FLT3抑制剂马来酸氟诺替尼在骨髓纤维化治疗中的首次人体 I/IIa 期安全性和有效性研究

原标题：First-in-Human Phase I/IIa Safety and Efficacy of Flonoltinib Maleate, a New Generation of JAK2/FLT3 Inhibitor in Myelofibrosis

发言人：陈俐娟

通讯作者：牛挺 

汇报时间：Sunday, December 8, 2024: 10:45 AM

汇报地点：Grand Hall C (Manchester Grand Hyatt San Diego)

Oral摘要号810：新型RIPK1抑制剂通过坏死凋亡治疗噬血细胞性淋巴组织细胞增生症的药理学及机制研究

原标题：Pharmacological and Mechanism Study of a New RIPK1 Inhibitor Via Necroptosis to Treat Hemophagocytic Lymphohistiocytosis

发言人：朱晋冰

通讯作者：牛挺

汇报时间：Monday, December 9, 2024: 4:00 PM

汇报地点：Room 6DE (San Diego Convention Center)

Oral摘要号1049：急性 B 细胞淋巴细胞白血病异基因造血干细胞移植后的微小剂量贝林妥欧单抗维持治疗

原标题：Mini-Dosed Blinatumomab Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute B-Cell Lymphoblastic Leukemia

发言人：季杰

通讯作者：刘霆

汇报时间：Monday, December 9, 2024: 5:30 PM

汇报地点：Room 6A (San Diego Convention Center)

壁报展示（Poster）

Poster 1579 Single-Nucleus Transcriptomics of FFPE Specimens from Mucosa-Associated Lymphoid Tissue Lymphoma Patients Reveal Tumor Heterogeneity and Changes in the Tumor Microenvironment during Relapse

第一作者:  孙旭

通讯作者：牛挺，赵艾琳

Session: 621. Lymphomas: Translational – Molecular and Genetic: Poster I

Time and Location:

Saturday, December 7, 2024: 5:30 PM-7:30 PM

Halls G-H (San Diego Convention Center

Poster 2208 Harnessing Ferroptosis and Photothermal Effects: A New Paradigm in Aggressive

第一作者: 王梦瑶

通讯作者：牛挺

Session: 802. Chemical Biology and Experimental Therapeutics: Poster I

Time and Location:

Saturday, December 7, 2024: 5:30 PM-7:30 PM

Halls G-H (San Diego Convention Center)

Poster 2840 Deciphering Clonal Evolution of Immunoglobulin Heavy Chain Locus Enhances Next-Generation Sequencing-Based Measurable Residual Disease Detection in Adult B-Acute Lymphoblastic Leukemia

第一作者: 代阳

通讯作者：刘霆

Session: 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis: Poster II

Time and Location:

Sunday, December 8, 2024: 6:00 PM-8:00 PM

Halls G-H (San Diego Convention Center)

Poster 2898 Venetoclax Plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for Elderly or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia: A Multicenter, Prospective Study

第一作者: 马洪兵

通讯作者：龚玉萍

Session: 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster II

Time and Location:

Sunday, December 8, 2024: 6:00 PM-8:00 PM

Halls G-H (San Diego Convention Center)

Poster 3512 Lower Respiratory Tract Pathogen Colonization Detected By Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid before Allogeneic Hematopoietic Stem Cell Transplantation and Its Predicting Value for Post-Transplant Infection

第一作者：张航

通讯作者：季杰

Session: 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II

Time and Location:

Sunday, December 8, 2024: 6:00 PM-8:00 PM

Halls G-H (San Diego Convention Center)

Poster 4027 An Erythrocyte-Based Delivery Platform for Leukemia Treatment

第一作者：陈梦然

通讯作者：吴俣，曲莹

Session: 401. Blood Transfusion: Poster III

Time and Location:

Monday, December 9, 2024: 6:00 PM-8:00 PM

Halls G-H (San Diego Convention Center)

Poster 4165 YL0712-3, a Novel ATR/ATM Inhibitor, Demonstrates Anti-Tumor Activity in TP53 Mutant DLBCL through Synthetic Lethality and Degradation of Mutant p53

第一作者：王力

通讯作者：牛挺

Session: 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster III

Time and Location:

Monday, December 9, 2024: 6:00 PM-8:00 PM

Halls G-H (San Diego Convention Center)

Poster 4488 Zanubrutinib Plus R-CHOP (ZR-CHOP) in Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Who Were Positron Emission Tomography-Positive after Two Cycles of R-CHOP: A Single-Arm, Open-Label, Multicenter Prospective Study

第一作者：王婕  李赫

通讯作者：牛挺

Session: 627. Aggressive Lymphomas: Pharmacologic Therapies: Poster III

Time and Location:

Monday, December 9, 2024: 6:00 PM-8:00 PM

Halls G-H (San Diego Convention Center)